Annual Cash & Cash Equivalents
$49.98 M
+$17.68 M+54.75%
December 31, 2021
Summary
- As of February 10, 2025, CCXI annual cash & cash equivalents is $49.98 million, with the most recent change of +$17.68 million (+54.75%) on December 31, 2021.
- During the last 3 years, CCXI annual cash & cash equivalents has risen by +$21.89 million (+77.93%).
Performance
CCXI Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$44.40 M
+$3.82 M+9.41%
June 30, 2022
Summary
- As of February 10, 2025, CCXI quarterly cash and cash equivalents is $44.40 million, with the most recent change of +$3.82 million (+9.41%) on June 30, 2022.
- Over the past year, CCXI quarterly cash and cash equivalents has dropped by -$32.81 million (-42.50%).
Performance
CCXI Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CCXI Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +54.8% | -42.5% |
| 3 y3 years | +77.9% | +14.6% |
| 5 y5 years | +24.9% | +106.5% |
CCXI Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -11.2% | -8.6% |
| 5 y | 5-year | at high | -35.4% | -86.7% | -27.3% |
| alltime | all time | at high | -83.1% | -86.7% | -93.8% |
ChemoCentryx Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $44.40 M(+9.4%) |
| Mar 2022 | - | $40.58 M(-18.8%) |
| Dec 2021 | $49.98 M(+54.7%) | $49.98 M(-46.7%) |
| Sep 2021 | - | $93.73 M(+21.4%) |
| Jun 2021 | - | $77.20 M(+12.6%) |
| Mar 2021 | - | $68.55 M(+112.2%) |
| Dec 2020 | $32.30 M(-17.6%) | $32.30 M(-42.5%) |
| Sep 2020 | - | $56.18 M(-83.1%) |
| Jun 2020 | - | $333.20 M(+460.6%) |
| Mar 2020 | - | $59.44 M(+51.7%) |
| Dec 2019 | $39.18 M(+39.5%) | $39.18 M(+9.1%) |
| Sep 2019 | - | $35.92 M(-7.3%) |
| Jun 2019 | - | $38.74 M(-51.2%) |
| Mar 2019 | - | $79.33 M(+182.4%) |
| Dec 2018 | $28.09 M(-29.8%) | $28.09 M(+16.5%) |
| Sep 2018 | - | $24.11 M(-64.9%) |
| Jun 2018 | - | $68.75 M(+125.0%) |
| Mar 2018 | - | $30.55 M(-23.7%) |
| Dec 2017 | $40.02 M(+232.8%) | $40.02 M(+122.8%) |
| Sep 2017 | - | $17.96 M(-16.5%) |
| Jun 2017 | - | $21.50 M(+13.4%) |
| Mar 2017 | - | $18.95 M(+57.6%) |
| Dec 2016 | $12.02 M | $12.02 M(-13.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2016 | - | $13.87 M(-36.8%) |
| Jun 2016 | - | $21.93 M(+63.4%) |
| Mar 2016 | - | $13.42 M(+4.7%) |
| Dec 2015 | $12.82 M(-20.2%) | $12.82 M(-12.0%) |
| Sep 2015 | - | $14.57 M(+25.9%) |
| Jun 2015 | - | $11.57 M(-54.5%) |
| Mar 2015 | - | $25.44 M(+58.2%) |
| Dec 2014 | $16.07 M(+56.7%) | $16.07 M(-23.1%) |
| Sep 2014 | - | $20.90 M(+59.4%) |
| Jun 2014 | - | $13.11 M(+12.7%) |
| Mar 2014 | - | $11.63 M(+13.4%) |
| Dec 2013 | $10.26 M(+21.3%) | $10.26 M(-54.0%) |
| Sep 2013 | - | $22.32 M(-55.6%) |
| Jun 2013 | - | $50.28 M(+332.1%) |
| Mar 2013 | - | $11.64 M(+37.6%) |
| Dec 2012 | $8.46 M(-78.9%) | $8.46 M(-35.5%) |
| Sep 2012 | - | $13.12 M(+375.9%) |
| Jun 2012 | - | $2.76 M(-86.7%) |
| Mar 2012 | - | $20.73 M(-48.4%) |
| Dec 2011 | $40.16 M(+233.1%) | $40.16 M(+447.0%) |
| Sep 2011 | - | $7.34 M(-29.0%) |
| Jun 2011 | - | $10.33 M(-14.3%) |
| Dec 2010 | $12.06 M(-42.8%) | $12.06 M |
| Dec 2009 | $21.08 M | - |
FAQ
- What is ChemoCentryx annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for ChemoCentryx?
- What is ChemoCentryx annual cash & cash equivalents year-on-year change?
- What is ChemoCentryx quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for ChemoCentryx?
- What is ChemoCentryx quarterly cash and cash equivalents year-on-year change?
What is ChemoCentryx annual cash & cash equivalents?
The current annual cash & cash equivalents of CCXI is $49.98 M
What is the all time high annual cash & cash equivalents for ChemoCentryx?
ChemoCentryx all-time high annual cash & cash equivalents is $49.98 M
What is ChemoCentryx annual cash & cash equivalents year-on-year change?
Over the past year, CCXI annual cash & cash equivalents has changed by +$17.68 M (+54.75%)
What is ChemoCentryx quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CCXI is $44.40 M
What is the all time high quarterly cash and cash equivalents for ChemoCentryx?
ChemoCentryx all-time high quarterly cash and cash equivalents is $333.20 M
What is ChemoCentryx quarterly cash and cash equivalents year-on-year change?
Over the past year, CCXI quarterly cash and cash equivalents has changed by -$32.81 M (-42.50%)